The aim of this study was to determine whether innate immune signalling influences the vascular repair process in response to mechanical injury of arteries in mice.
Introduction
Excessive proliferation of vascular smooth muscle cells (VSMCs) characterizes vascular repair after injury and is also a feature of atherosclerosis progression. The proliferative response may be inherent to the repair process, but can also lead to restenosis when excessive. In-stent restenosis occurs in about one out of four patients treated with coronary artery stents, causing recurring symptoms that may require a new intervention.
Animal models of vascular injury, such as the mouse collar model used here, have been used for both mechanistic studies on the pathophysiology of neointima formation as well as assessment of potential anti-atherosclerotic interventions.
1 Inflammation and cytokines have been shown to contribute to neointima formation in ligated carotid arteries. 2 Also, the adaptive immune system has a role in regulating the arterial response to mechanical injury. During arterial injury, autoantibodies are generated that specifically bind to injured but not uninjured arterial tissue. 3 Rag-1-deficient mice that lack T and B cells display enhanced neointima formation when compared with control mice after mechanical arterial injury. 3, 4 Reconstitution of Rag-1-deficient mice with B cells from wild-type animals reduces neointima formation compared with unreconstituted Rag-1-deficient mice, indicating that B cells have a role in the response to arterial injury. 3 Mice lacking the lipid antigen-presenting molecule CD1d also have reduced neointima formation in response to arterial injury, suggesting that presentation of lipid antigens through the CD1d-natural killer T cell pathway modulates vascular repair responses. 5 Activation of VSMCs in response to injury is accompanied by an increased proliferation and change to a proinflammatory phenotype characterized by the activation of NF-kB, increased expression of adhesion molecules and chemokines. 6 -8 Little is known about the molecular activators that triggers the phenotypic changes associated with the proinflammatory proliferating VSMCs. Various endogenous proteins released during tissue damage and sterile inflammation are thought to act as ligands for pattern recognition receptors of the innate immune system to induce sterile inflammation. 9, 10 Toll-like receptors (TLRs) are among the best understood pattern recognition receptors, and they are the main recognition receptors in the host response to pathogens. The TLR family recognizes a wide range of microbial ligands, but several endogenous ligands of TLRs have also been proposed, including high-mobility group box 1, fibronectin extra domain A, heat shock proteins, and free fatty acids. 11, 12 In addition to endogenous TLR ligands, interleukin (IL)-1a has been proposed to be critical in sterile inflammation caused by tissue damage. 13 Interestingly, the IL-1 receptor and most TLRs utilize the same adaptor protein, MyD88, to initiate signalling cascades that lead to proinflammatory cytokine release.
14, 15 Here, we explore the role of innate immune signalling in the vascular response to injury by using MyD88-deficient mice and show that inhibition of the type I IL-1 receptor (IL-1RI) by antibody blockade reduces neointima formation after vascular injury.
Methods

Animals
The experimental protocol used in the study conforms with the Guide for the Care 
Periadventitial collar injury
Animals were selected for surgery when they were 16-18 weeks old. Mice were briefly anaesthesized with isoflurane followed by intraperitoneal (ip) injection of ketamine/xylazine (9:1) dissolved in phosphatebuffered saline (PBS; 1:1 dilution). A dose of 150 mL per 30 g of mice was used. The mice were placed supine on the operation table, and the ventral area around the upper neck was shaved. Right carotid artery was carefully exposed under a stereo microscope. A non-occlusive plastic collar was placed around the right carotid artery, and the skin incision was closed as described previously. 5 Sham surgeries were performed following the same protocol, but without placement of collars. Mice were killed at 3 or 21 days after collar placement, and carotid injured arteries were perfusion fixed using PBS followed by Histochoice (Amresco Inc., Solon, OH, USA) injection via the right atrium under constant pressure and drained via the femoral artery. Arteries were dissected out and stored in Histochoice at 48C for 5 -8 h before they were processed for further analyses.
Morphometric analysis
The carotid arteries were removed from Histochoice and dehydrated in 30% sucrose phosphate buffer and embedded in OCT (Tissue-Tek OCT, Sakura Japan) compound for sectioning. Carotid arteries were frozen and sectioned (7 mm thickness) using a cryostat microtome (Microme HM 560, Sweden). Sections were air dried for 1 h and frozen at 2208C until stained. Sections were stained with van Gieson/Accustain elastin stain (Sigma-Aldrich ACCUSTAIN; Egham UK). Areas of interest were calculated using the image software Zeiss Axiovision (Zeiss). The medial area was calculated as the area between the external and the internal elastic laminae. Lesions with neointima formation were encircled and the neointima areas calculated. The neointima area was also normalized to the medial area and expressed as the intima to media ratio.
Immunofluorescence microscopy
Confocal immunofluorescence experiments were performed as previously described. 16 Briefly, arterial sections were permeabilized with 0.2% Triton X-100 in PBS for 10 min (Sigma-Aldrich) and blocked for 2 h with 2% (w/v) bovine serum albumin (Sigma-Aldrich) in PBS. Primary monoclonal antibodies, rat anti-mouse CD68 (clone FA-11, Serotec, USA), and TLR4 (clone MTS510; Santa Cruz Biotechnology, Inc) were applied overnight at 48C. Cy5-labelled secondary antibody (donkey anti-rat; Jackson ImmunoResearch Laboratories, Wes Grove, PA, USA) was applied for 1 h at room temperature. The fluorescent nucleic acid dye SYTOX Green (1:3000; Molecular Probes, Invitrogen, Paisley, UK) was used for nuclear identification. Specificity of immune staining was confirmed by the absence of fluorescence in arteries incubated with primary or secondary antibodies alone. After washing, preparations were mounted (Aqua Polymount mounting medium; Polysciences) and examined at ×10 and ×63 magnification (numerical apertures, 0.3 and 1.4, respectively) in a Zeiss LSM 5 Pascal laser scanning confocal microscope (Zeiss, Jena, Germany). Expression of TLR4 and CD68 was determined by monitoring Cy5 fluorescence (excitation 633 nm; emission .650 nm; Jackson ImmunoResearch), and nuclei were identified by monitoring green fluorescence (excitation 488 nm; emission 524 nm). For quantification, multiple fields for each carotid section were imaged and analysed under blind conditions. Three to four boxes of defined dimensions were randomly positioned within the vessel wall and mean pixel intensity (range 0 -255 greyscale values) after background subtraction was calculated using the Zeiss LSM 5 analysis software. For each artery and target (TLR4 or CD68), four sections were analysed. For CD68 measurements, data have been expressed as a percentage of CD68-positive cells of the total number of cells present in the medial layer.
For non-confocal immunofluorescence detection, frozen arterial sections were air dried at RT, incubated in 2208C methanol for 10 min, and then stored in PBS. For detection of a-smooth muscle actin and TLR4, vessels were double stained using a MOM-kit (Mouse-On-Mouse, Vector labs) according to the manufacturer's instructions. Sections were incubated overnight with an antibody against a-smooth muscle actin (1A4, Sigma) and anti-TLR4 antibody (same as for confocal images; see above). Antigen distribution was visualized with FITC-linked streptavidin (Amersham), and Cy3-linked goat anti-rat IgG (Jackson) for a-smooth muscle actin and anti-TLR4, respectively. Images were obtained using a Zeiss Axiophot 2 microscope and a Hamamatsu C4742-95 camera with Openlab 5 software (Improvision) for image processing.
IL-1RI and TLR4 antibody blockade
Mice were treated with 100 mg rat IgG1 control antibody or 100 mg antimouse CD121a (IL-1 R, Type I/p80) or anti-mouse TLR4/MD2 complex blocking antibodies (Biolegend, San Diego, CA, USA) by ip injection 2 Vascular repair is regulated by IL-1RI and MyD88 signalling days before the collar placement. A second dose antibody was given 7 days later.
Plasma IL-1b and IL-12p40 release upon LPS stimulation
Blood plasma was collected from mice at Day 21 after surgically placing collars around the right carotid arteries. The plasma level of IL-1b was measured with a MILLIPLEX MAP cytokine kit (Millipore, Billerica, MA, USA) on a Luminex LX100 instrument (Luminex corp., Austin, TX, USA) following the manufacturer's protocol. Single cell suspensions generated from spleens removed from mice 3 days after ip injection of anti-TLR4 or PBS were stimulated with increasing concentrations of lipopolysaccharide (LPS) overnight. IL-12p40 release to cell culture medium was measured with ELISA (R&D Systems, Minneapolis, MN, USA) following the manufacturer's protocol.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5 software (GraphPad Software Inc., LaJolla, CA, USA) or SPSS 15 (SPSS Inc., Chicago, IL, USA). Two-way ANOVA, or Kruskal -Wallis, tests were used to evaluate statistically significant differences between multiple groups, after which Mann-Whitney tests were performed for paired comparisons if the multiple group comparison indicated a difference between groups. Results were considered statistically significant at P , 0.05.
Results
To induce vascular injury, we placed a non-obstructive plastic collar around the carotid artery in MyD88-deficient and C57Bl/6 control mice. After 21 days, the intima-media ratio was increased in injured carotid arteries compared with arteries from sham-operated C57Bl/ 6 mice indicative of a strong response to injury ( Figure 1A and B) . In contrast, the intima-media ratio in injured MyD88-deficient arteries was not increased compared with arteries from sham-operated mice ( Figure 1C and D) . Thus, MyD88-dependent innate immune signalling promotes neointima formation upon vascular injury. Interestingly, the perimeter of the external elastic lamina was increased in injured arteries from both MyD88-deficient and C57Bl/6 mice compared with arteries from sham-operated mice ( Figure 1F ), indicating (E) Intima-media ratio in arteries from collar-injured and sham-operated mice. Two-way ANOVA analysis revealed a significant difference between the genotypes (P , 0.001) and the genotype -treatment interaction (P 0.001), whereas the treatment alone was only borderline significant (P 0.051). **P , 0.01 by the MannWhitney non-parametric test. (F ) Intima areas in arteries from collar-injured and sham-operated mice. Two-way ANOVA analysis revealed a significant difference between the genotypes and the genotype -treatment interaction (P , 0.001). (G) The perimeter of the external elastic lamina in arteries from collar-injured and sham-operated mice. Two-way ANOVA analysis revealed a significant difference between the treatments (P 0.003) and the genotype (P 0.045). Each data point in the graphs represents the measured average of one mouse. *P , 0.05 and **P , 0.01 by the Mann-Whitney non-parametric test.
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that outward remodelling upon vascular injury is not dependent on MyD88 signalling.
Inflammation, determined as the percentage of CD68-positive leucocytes/macrophages counted on confocal immunofluorescence images, was increased in injured arteries at Day 21 compared with arteries from sham-operated C57Bl/6 mice (Figure 2A-E) . In contrast, very few CD68-positive cells were observed in the MyD88-deficient injured arteries indicating that leucocyte infiltration during neointima formation is dependent on MyD88 signalling.
To study if arterial injury alters the expression of inflammatory mediators locally, we measured anti-TLR4 staining intensity on Figure 3A-F) . Interestingly, the expression of TLR4 was dramatically increased in the media of injured arteries at Day 3 when compared with contralateral carotid arteries or arteries from sham-operated mice ( Figure 3G ). This TLR4 immunofluorescence co-localized with a-smooth muscle actin, indicating that VSMC up-regulation of TLR4 is an early event in the vascular response to injury (Figure 3I-P) . At Day 21 after surgeries, TLR4 expression was significantly reduced and not different from contralateral arteries.
To determine whether carotid injury was associated with systemic inflammation, we measured plasma IL-1b in injured and sham-operated mice. IL-1b expression was elevated at Day 21 in plasma from injured mice compared with sham-operated mice ( Figure 3H ). MyD88 deficiency did not alter plasma IL-1b levels, indicating that release of IL-1b after injury does not depend on MyD88 signalling ( Figure 3H) .
Previous studies have implicated both TLR4 and IL-1 in the vascular response to injury. 2, 17 This notion is also in line with the present observation of reduced neointima formation in MyD88-deficient mice since both TLR4 signalling and IL-1 receptor (IL-1RI) signalling engage MyD88. To test the relative importance of TLR4 and IL-1RI activation in the vascular response to injury, C57Bl/6 mice were administered anti-IL-1RI, anti-TLR4, or control antibody 2 days before injury and 7 days later. At Day 21 after injury, the neointima formation was reduced by 80% in mice that had received anti-IL-1 receptor antibody compared with mice treated with control antibody, whereas no difference in the neointima area was observed between mice that had been treated with TLR4 and control antibodies ( Figure 4D and E). The perimeter of the external elastic lamina did not differ between any of the antibody-treated groups (data not shown). TLR4 blockade with the antibody used in this study has been shown to impair LPS-induced cytomegalovirus reactivation in mice in vivo. 18 To verify if in vivo administration of anti-TLR4 had an impact on TLR4 responses, we removed spleens from mice 3 days after ip injection of anti-TLR4 and generated single cell splenocyte suspensions that were stimulated with increasing concentrations of LPS overnight. Splenocytes from mice injected with anti-TLR4 antibody displayed reduced LPS-stimulated IL-12p40 production compared with splenocytes from mice injected with PBS, indicating that in vivo inhibition of the TLR4 signalling was achieved ( Figure 4F ). Taken together, our data show that inhibition of IL-1 receptor, but not TLR4, signalling has a considerable effect on the vascular response to injury.
Discussion
Here, we show that MyD88-dependent innate immune signalling modulates the vascular response to injury in carotid arteries from mice. Vascular injury was demonstrated to be associated with increased levels of circulating IL-1b, as well as an increased local expression of TLR4 on VSMCs in the arteries, providing evidence for activation of two separate MyD88-dependent signalling pathways. Pretreatment with blocking antibody against IL-1RI reduced neointima formation, whereas TLR4 blockade had no effect. These results suggest an important role for IL-1RI activation in the vascular response to injury. The increased expression of TLR4 in injured arteries does not appear to play a role in regulating the extent of the subsequent neointima formation. However, it remains to be investigated if other receptors upstream of MyD88, such as IL-18R and other TLRs, also play a role in the vascular response to injury. Our results and previous studies support the notion that IL-1 signalling is an important modulator of the vascular response to injury. IL-1RI-deficient mice have been shown to develop less neointima than the controls after unilateral ligation of the common carotid artery.
2,19 IL-1 receptor signalling is counteracted by the endogenous inhibitor IL-1 receptor antagonist (IL-1Ra). IL-1Ra-deficient mice display increased neointima formation compared with wild-type mice after femoral artery injury induced by an external vascular collar. 20 Also, mice receiving subcutaneous IL-1Ra showed reduced neointima formation after carotid ligation. 19 Chimeric mice, either IL-1RI-competent mice receiving IL-1RI-deficient bone marrow or IL-1RI-deficient mice receiving IL-1RI competent marrow, both displayed reduced neointima formation compared with transplanted control mice with fully established IL-1RI expression showing that the vascular response to injury involves both recruited inflammatory cells of bone marrow origin and arterial wall cells. 19 IL-1a and IL-1b can both activate IL-1RI signalling, and IL-1a mRNA has been detected in ligated carotid arteries at 4 days after surgery. 2 Ligation of the carotid artery in IL-1b-deficient, but not in IL-1a-deficient mice, resulted in reduced neointima formation compared with control mice. 19 On the other hand, IL-1a signalling via IL-1R has been implicated in the sterile inflammatory response to dead cells and tissue injury. In a study using IL-1R mutant mice, it was shown that the IL-1a/ IL-1R pathway induced a strong recruitment of neutrophils in response to injured cells, whereas monocyte recruitment was much less dependent on this pathway. 13 Thus, the vascular response to injury that involves monocytes might not depend on IL-1a-mediated neutrophil recruitment. 21 IL-1a may still have an important function as the signalling mediator. Experiments using RNA interference to knock down IL-1a expression have shown that endogenous IL-1a is critical for TLR-induced proliferation of human aortic SMCs. 22 TLR4 signalling seems to promote a pro-inflammatory phenotype in human and mouse arterial VSMCs in vitro, and it has been speculated that increased TLR expression may be a feature of this phenotype. 23 Thus, it could be hypothesized that IL-1a might have had a role in inducing the strong expression of TLR4 on VSMCs, which we observed at Day 3 after arterial injury. The induction of TLR4 expression in vivo may need additional yet unidentified factors concentrated at the site of injury. The transient increase in TLR4 expression on VSMCs suggests that TLR4 may play a role in the early response to injury. Functional TLR4 is expressed in proliferating VSMCs in culture 24, 25 and in VSMCs Vascular repair is regulated by IL-1RI and MyD88 signalling in the wall of human atherosclerotic coronary arteries, even in regions with few inflammatory cells. 26 Mice with a targeted deletion of TLR4 develop less atherosclerosis than control mice. 27 In addition, application of a periadventitial collar containing LPS around the femoral artery in TLR4-deficient mice resulted in reduced neointima formation compared with TLR4-competent control mice, indicating that neointima formation is TLR4-dependent in the presence of a TLR4 ligand. 28 Intriguingly, in the present study anti-TLR4 failed to reduce neointima formation, suggesting a lack of sufficient TLR4 ligands capable of promoting neointima formation after collar injury in the absence of LPS. The lack of effect of anti-TLR4 treatment should be interpreted with caution. Despite the fact that in vivo administration of anti-TLR4 was able to block LPS-induced IL-12p40 production, we cannot rule out that the local tissue concentrations of the blocking antibody were insufficient to impact neointima formation.
In line with our results, others have shown that lack of TLR4 had no impact on neointima formation in experiments using a periadventitial gelatine-filled collar on the femoral artery in TLR4-deficient and control mice. 17 Many endogenous ligands of TLR4 have been reported to be present after tissue injury, 9 and extracellular domain A of fibronectin and Hsp60 are present in atherosclerotic arteries. 29 Even though endogenous ligands have not been measured in this study, it is possible that the lack of effect of the TLR4 antibody treatment on neointima formation may be due to a modest induction of endogenous ligands in our model, or by their inability to engage TLR4 signalling to a sufficient extent to affect neointima size. It should be pointed out that the collar model used here explores responses to vascular injury in a non-hyperlipidaemic environment and the injury response during hyperlipidaemia may display other ligands and altered signalling patterns. The main characteristics of the collar approach used in this study are the lack of mechanical denudation of the endothelium, medial injury, or interruption of blood flow. 1, 30, 31 However, endothelial cells lining the lumen of the artery have been shown to slough off within 1 day after the injury allowing platelet adhesion at the site. 32 Even if the media was not directly injured, it seems to respond immediately to the injury expressing TLR4 at Day 3 after injury. The exact role of TLR4 signalling in proliferating VSMCs during vascular repair after injury and atherosclerosis progression remains to be fully elucidated. The release of mature IL-1 cytokines requires proteolytic processing by caspase-1. Interestingly, apoptosis-associated speck-like protein, a component of inflammasomes that regulates caspase-1 activity, has recently been shown to contribute to neointima formation after wire-mediated vascular injury in femoral arteries of mice. 33 Inflammasomes can be activated by endogenous ligands such as cholesterol crystals present in atherosclerotic lesions. 34 Inflammasome activation is consistent with our findings reported here. The identity of any endogenous ligands produced during vascular injury that might activate inflammasomes and IL-1 release in the absence of hypercholesterolaemia remains obscure. TLR4 has been shown to be involved in outward arterial remodelling in mice in both a femoral collar model and a carotid ligation model. 17 Interestingly, our data in MyD88-deficent mice show that outward remodelling upon injury occurred regardless of MyD88 expression, indicating that outward remodelling progresses via another signalling pathway than the TLR4-MyD88 route. In summary, we have confirmed that IL-1R signalling is a critical event in the vascular response to injury. Furthermore, we demonstrated that inhibition of IL-1 signalling could be a viable therapeutic option for reducing the vascular response to injury and clinical complications, such as in-stent restenosis after balloon angioplasty and stent placement.
